| Interleukin-12 as an in situ cancer vaccine component: a review EM Cheng, NW Tsarovsky, PM Sondel, AL Rakhmilevich Cancer Immunology, Immunotherapy 71 (9), 2057-2065, 2022 | 34 | 2022 |
| Radiation Augments the Local Anti-Tumor Effect of In Situ Vaccine With CpG-Oligodeoxynucleotides and Anti-OX40 in Immunologically Cold Tumor Models AA Pieper, LM Zangl, DV Speigelman, AS Feils, A Hoefges, ... Frontiers in Immunology 12, 763888, 2021 | 18 | 2021 |
| Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist AA Pieper, DV Spiegelman, MAR Felder, AS Feils, NW Tsarovsky, ... Cancer Immunology, Immunotherapy 72 (7), 2459-2471, 2023 | 3 | 2023 |
| Antibody landscape of C57BL/6 mice cured of B78 melanoma via immunotherapy A Hoefges, SJ McIlwain, AK Erbe, N Mathers, A Xu, D Melby, K Tetreault, ... bioRxiv, 2023 | 2 | 2023 |
| Bispecific GD2 x B7-H3 Antibody Improves Tumor Targeting and Reduces Toxicity while Maintaining Efficacy for Neuroblastoma AK Erbe, AS Feils, A Hampton, ZT Rosenkrans, M Felder, J Wiwczar, ... bioRxiv, 2024.05. 23.595588, 2024 | 1 | 2024 |
| A combined radio-immunotherapy regimen eradicates late-stage tumors in mice AL Rakhmilevich, NW Tsarovsky, M Felder, J Zaborek, S Moram, AK Erbe, ... Frontiers in Immunology 15, 1419773, 2024 | | 2024 |
| Histoplasty Modification of the Tumor Microenvironment in a Murine Preclinical Model of Breast Cancer AA Pieper, NA Stowe, S Periyasamy, BM Burkel, NW Tsarovsky, AP Singh, ... Journal of Vascular and Interventional Radiology 35 (6), 900-908. e2, 2024 | | 2024 |
| Antibody landscape of C57BL/6 mice cured of B78 melanoma via a combined radiation and immunocytokine immunotherapy regimen A Hoefges, SJ McIlwain, AK Erbe, N Mathers, A Xu, D Melby, K Tetreault, ... Frontiers in Immunology 14, 1221155, 2023 | | 2023 |
| 87 Monitoring in vivo CD8 T and tumor cell metabolic changes in solid tumors during an in situ vaccine using autofluorescence imaging AR Heaton, A Hoefges, NJ Burkard, AS Feils, NW Tsarovsky, GM Lublin, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 141 C57BL/6 mice cured of B78 melanoma frequently develop antibodies that recognize a 4 amino acid binding motif (SDTG) A Hoefges, PM Sondel, N Mathers, SJ Mcilwain, K Tetreault, AA Hampton, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Cyclophosphamide augments the efficacy of in situ vaccination in a mouse melanoma model N Tsarovsky, M Felder, M Heck, J Slowinski, K Rasmussen, ... Frontiers in Oncology 13, 1200436, 2023 | | 2023 |
| In vivo multiphoton autofluorescence imaging is sensitive to CD8 T cell and tumor cell metabolic changes during immunotherapy in a murine melanoma model AR Heaton, A Hoefges, PR Rehani, NJ Burkard, AS Feils, DV Spiegelman, ... Cancer Research 83 (7_Supplement), 2389-2389, 2023 | | 2023 |
| CD4 T cell-driven response to immunotherapy against mouse melanoma tumors AK Erbe, AS Feils, A Hampton, D Spiegelman, N Tsarovsky, A Hoefges, ... Cancer Research 83 (7_Supplement), 4142-4142, 2023 | | 2023 |
| Antibody landscape of C57BL/6 mice cured of B78 melanoma via a combined radiation and immunocytokine immunotherapy regimen JDG Duarte, PM Sondel, A Hoefges, SJ McIlwain, AK Erbe, N Mathers, ... | | 2023 |
| A combined radio-immunotherapy regimen eradicates late-stage melanoma in mice. S Moram, A Rakhmilevich, N Tsarovsky, M Felder, A Erbe, A Pieper, ... | | 2023 |
| 72 Intravital multiphoton autofluorescence imaging is sensitive to changes in CD8 T cell and tumor cell metabolism during immunotherapy in a murine melanoma model A Heaton, A Hoefges, P Rehani, N Burkard, A Feils, D Spiegelman, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| The influence of MHC class I and II on T cell responses in mouse melanoma AK Erbe, A Feils, M Heck, S VandenHeuvel, J Castillo, A Hampton, ... Cancer Research 82 (12_Supplement), 1385-1385, 2022 | | 2022 |
| Tumor-targeting and efficacy of B7H3/GD2 bispecific SNIPER antibodies AK Erbe, A Feils, Z Rosenkrans, J Wiwczar, D Gerhardt, B Hammer, ... Cancer Research 82 (12_Supplement), 2019-2019, 2022 | | 2022 |
| 599 Cyclophosphamide augments the efficacy of an in situ vaccine in a mouse melanoma model N Tsarovsky, M Felder, M Heck, J Slowinski, K Rasmussen, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A629-A629, 2021 | | 2021 |
